THB Asset Management’s Lifecore Biomedical LFCR Stock Holding History

THB Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-215,310	Closed	-$2.44M	–	174
2019 Q4	$2.44M	Sell	215,310 -190,779	-47%	-$2.03M	0.45%	77
2019 Q3	$4.41M	Sell	406,089 -48,542	-11%	-$528K	0.82%	52
2019 Q2	$4.26M	Sell	454,631 -124,290	-21%	-$1.25M	0.68%	61
2019 Q1	$7.11M	Sell	578,921 -17,694	-3%	-$216K	1.03%	36
2018 Q4	$7.06M	Sell	596,615 -27,363	-4%	-$376K	1.05%	35
2018 Q3	$8.98M	Sell	623,978 -51,483	-8%	-$712K	1.1%	29
2018 Q2	$10.1M	Sell	675,461 -53,260	-7%	-$740K	1.23%	26
2018 Q1	$9.51M	Sell	728,721 -12,467	-2%	-$164K	1.24%	29
2017 Q4	$9.34M	Buy	741,188 +9,079	+1%	+$115K	1.23%	27
2017 Q3	$9.48M	Sell	732,109 -113,330	-13%	-$1.49M	1.3%	23
2017 Q2	$12.6M	Sell	845,439 -38,840	-4%	-$541K	1.62%	9
2017 Q1	$10.6M	Sell	884,279 -12,260	-1%	-$155K	1.32%	17
2016 Q4	$12.4M	Buy	896,539 +24,729	+3%	+$343K	1.53%	8
2016 Q3	$11.7M	Buy	871,810 +105,210	+14%	+$1.27M	1.71%	9
2016 Q2	$8.25M	Buy	766,600 +454,720	+146%	+$5.02M	1.07%	37
2016 Q1	$3.27M	Sell	311,880 -6,130	-2%	-$67.3K	0.37%	92
2015 Q4	$3.76M	Buy	318,010 +182,300	+134%	+$2.24M	0.4%	93
2015 Q3	$1.58M	Buy	135,710 +6,500	+5%	+$86.1K	0.16%	165
2015 Q2	$1.86M	Buy	+129,210	New	+$1.86M	0.14%	185
2013 Q4	–	Sell	-157,922	Closed	-$1.93M	–	274
2013 Q3	$1.93M	Sell	157,922 -87,650	-36%	-$1.22M	0.12%	205
2013 Q2	$3.24M	Buy	+245,572	New	+$3.4M	0.22%	169

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

THB Asset Management's LFCR Position: Q1 2020 in Review

THB Asset Management sold out of Lifecore Biomedical (LFCR) in Q1 2020, closing a stake of 215,310 shares — an estimated $2.44M sold.

THB Asset Management first reported a position in LFCR in Q2 2013 and held it in 21 quarters. The position peaked at $12.6M in Q2 2017. 88 funds tracked by Wall St. Rank hold LFCR as of Q1 2020.

THB Asset Management reported no remaining Lifecore Biomedical position as of Q1 2020 after selling out during the quarter.
THB Asset Management sold 215,310 Lifecore Biomedical shares in Q1 2020, an estimated $2.44M.
THB Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 21 quarters.
THB Asset Management's Lifecore Biomedical position peaked at $12.6M in Q2 2017.
88 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2020.

Based on THB Asset Management's 13F filing for Q1 2020, filed 6 May 2020.